Citation Information :
Angelica Zoppi M. Diagnostic Prenatal Invasive Procedures in Obstetrics. Donald School J Ultrasound Obstet Gynecol 2013; 7 (4):426-428.
Chorionic villus sampling and acceptance rate of prenatal diagnosis. Prenatal Diagn 1987 Sep;7(7):531-533.
Transabdominal chorionic villus sampling: fetal loss rate in relation to maternal and gestational age. Prenat Diagn 1992;12(10):815-820.
Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am 2002 Jun;29(2):305-328, vi-vii.
Fetal nuchal translucency screening in 12,495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001 Dec;18(6):649-651.
Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193(2):322-326.
Changes in the approach for invasive prenatal diagnosis in 35,127 cases at a single center from 1977 to 2004. Fetal Diagn Ther 2006;21(4):348-354.
Prenatal genetic diagnosis through chorionic villus sampling. In Milunsky A, editor. Genetic disorders and the fetus: diagnosis, prevention, treatment. 6th ed. Baltimore: Wiley-Blackwell Publisher; 2009. p 160-193.
Danish Fetal Medicine Research Group. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008 Nov;337:a2547.
Ward P. The impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England. Ultrasound Obstet Gynecol 2013 May;41(5):526-529.
Improved first-trimester aneuploidy risk assessment: an evolving challenge of training in invasive prenatal diagnosis. Ultrasound Obstet Gynecol 2013 May;41(5):486-488.